Does the media prefer DGX or HIMS?

In the previous week, Hims & Hers Health had 20 more articles in the media than Quest Diagnostics. MarketBeat recorded 34 mentions for Hims & Hers Health and 14 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.26 beat Hims & Hers Health's score of 0.10 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 4 Very Positive mention(s) 5 Positive mention(s) 24 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer HIMS or GH?

In the previous week, Hims & Hers Health had 14 more articles in the media than Guardant Health. MarketBeat recorded 34 mentions for Hims & Hers Health and 20 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.82 beat Hims & Hers Health's score of 0.10 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 4 Very Positive mention(s) 5 Positive mention(s) 24 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 8 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HIMS or BTSG?

In the previous week, Hims & Hers Health had 26 more articles in the media than BrightSpring Health Services. MarketBeat recorded 34 mentions for Hims & Hers Health and 8 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.25 beat Hims & Hers Health's score of 0.10 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 4 Very Positive mention(s) 5 Positive mention(s) 24 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral BrightSpring Health Services 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TEM or HIMS?

In the previous week, Hims & Hers Health had 11 more articles in the media than Tempus AI. MarketBeat recorded 34 mentions for Hims & Hers Health and 23 mentions for Tempus AI. Tempus AI's average media sentiment score of 0.74 beat Hims & Hers Health's score of 0.10 indicating that Tempus AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 6 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Hims & Hers Health 4 Very Positive mention(s) 5 Positive mention(s) 24 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Hims & Hers Health (HIMS) Competitors

$27.52 -0.38 (-1.35%)

Closing price 09/10/2026 03:59 PM Eastern

Extended Trading

$27.30 -0.23 (-0.82%)

As of 07:40 AM Eastern

Compare

HIMS vs. DGX, GH, BTSG, FMS, and TEM

Should you buy Hims & Hers Health stock or one of its competitors? Hims & Hers Health's main competitors and comparable companies include Quest Diagnostics (DGX), Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), and Tempus AI (TEM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hims & Hers Health compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

In the previous week, Hims & Hers Health had 20 more articles in the media than Quest Diagnostics. MarketBeat recorded 34 mentions for Hims & Hers Health and 14 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.26 beat Hims & Hers Health's score of 0.10 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quest Diagnostics	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	4 Very Positive mention(s)	5 Positive mention(s)	24 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Quest Diagnostics has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	2.31	$992M	$9.42	24.54
Hims & Hers Health	$2.35B	2.74	$128.37M	-$0.63	N/A

Quest Diagnostics presently has a consensus price target of $236.31, indicating a potential upside of 2.23%. Hims & Hers Health has a consensus price target of $32.50, indicating a potential upside of 18.09%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

88.1% of Quest Diagnostics shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Quest Diagnostics has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, indicating that its stock price is 142% more volatile than the broader market.

Quest Diagnostics has a net margin of 9.18% compared to Hims & Hers Health's net margin of -5.51%. Quest Diagnostics' return on equity of 16.01% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.18%	16.01%	7.27%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Summary

Quest Diagnostics beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Guardant Health?

Hims & Hers Health (NYSE:HIMS) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Hims & Hers Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.74	$128.37M	-$0.63	N/A
Guardant Health	$982.02M	21.73	-$416.28M	-$3.49	N/A

Hims & Hers Health currently has a consensus target price of $32.50, suggesting a potential upside of 18.09%. Guardant Health has a consensus target price of $188.13, suggesting a potential upside of 18.30%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	24 Buy rating(s)	1 Strong Buy rating(s)	2.96

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hims & Hers Health has a net margin of -5.51% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Guardant Health	-38.33%	N/A	-25.40%

Hims & Hers Health has a beta of 2.42, suggesting that its stock price is 142% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market.

In the previous week, Hims & Hers Health had 14 more articles in the media than Guardant Health. MarketBeat recorded 34 mentions for Hims & Hers Health and 20 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.82 beat Hims & Hers Health's score of 0.10 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	5 Positive mention(s)	24 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	8 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hims & Hers Health beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to BrightSpring Health Services?

Hims & Hers Health (NYSE:HIMS) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

Hims & Hers Health currently has a consensus target price of $32.50, indicating a potential upside of 18.09%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 22.16%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

BrightSpring Health Services has a net margin of 2.55% compared to Hims & Hers Health's net margin of -5.51%. BrightSpring Health Services' return on equity of 16.73% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
BrightSpring Health Services	2.55%	16.73%	5.24%

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.74	$128.37M	-$0.63	N/A
BrightSpring Health Services	$12.91B	0.89	$190.67M	$1.66	34.87

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Hims & Hers Health has a beta of 2.42, indicating that its share price is 142% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, indicating that its share price is 84% more volatile than the broader market.

In the previous week, Hims & Hers Health had 26 more articles in the media than BrightSpring Health Services. MarketBeat recorded 34 mentions for Hims & Hers Health and 8 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.25 beat Hims & Hers Health's score of 0.10 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	5 Positive mention(s)	24 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	6 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.53
Hims & Hers Health	$2.35B	2.74	$128.37M	-$0.63	N/A

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 34 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 34 mentions for Hims & Hers Health and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.50 beat Hims & Hers Health's score of 0.10 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	Positive
Hims & Hers Health	Neutral

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $23.57, indicating a potential upside of 5.90%. Hims & Hers Health has a consensus target price of $32.50, indicating a potential upside of 18.09%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, suggesting that its stock price is 142% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Hims & Hers Health's net margin of -5.51%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Summary

Fresenius Medical Care AG & Co. KGaA and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Tempus AI has a beta of 3.72, indicating that its share price is 272% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, indicating that its share price is 142% more volatile than the broader market.

In the previous week, Hims & Hers Health had 11 more articles in the media than Tempus AI. MarketBeat recorded 34 mentions for Hims & Hers Health and 23 mentions for Tempus AI. Tempus AI's average media sentiment score of 0.74 beat Hims & Hers Health's score of 0.10 indicating that Tempus AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	6 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Hims & Hers Health	4 Very Positive mention(s)	5 Positive mention(s)	24 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tempus AI presently has a consensus price target of $68.78, indicating a potential upside of 17.09%. Hims & Hers Health has a consensus price target of $32.50, indicating a potential upside of 18.09%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Hims & Hers Health has higher revenue and earnings than Tempus AI. Hims & Hers Health is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.33	-$245.03M	-$1.44	N/A
Hims & Hers Health	$2.35B	2.74	$128.37M	-$0.63	N/A

Hims & Hers Health has a net margin of -5.51% compared to Tempus AI's net margin of -17.77%. Hims & Hers Health's return on equity of -6.51% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Hims & Hers Health beats Tempus AI on 9 of the 16 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$6.51B	$9.91B	$7.21B	$23.36B
Dividend Yield	N/A	2.60%	2.56%	3.78%
P/E Ratio	-43.69	33.79	272.84	28.46
Price / Sales	2.74	5.03	625.41	20.61
Price / Cash	33.34	125.92	77.33	34.40
Price / Book	11.56	5.29	10.41	4.70
Net Income	$128.37M	$313.25M	$3.49B	$1.07B
7 Day Performance	-0.50%	-1.37%	-3.16%	-2.42%
1 Month Performance	-11.02%	-0.88%	0.02%	-2.95%
1 Year Performance	-46.85%	13.48%	17.33%	8.84%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	2.8734 of 5 stars	$27.52 -1.4%	$32.50 +18.1%	-42.5%	$6.51B	$2.35B	N/A	2,442	Trending News
DGX Quest Diagnostics	4.4846 of 5 stars	$235.78 -0.6%	$236.31 +0.2%	+28.2%	$26.02B	$11.04B	25.03	57,000	Positive News Analyst Forecast Analyst Revision
GH Guardant Health	3.2006 of 5 stars	$160.91 -0.3%	$184.58 +14.7%	+181.1%	$21.59B	$982.02M	N/A	2,506	Analyst Forecast Gap Down
BTSG BrightSpring Health Services	4.6761 of 5 stars	$62.48 +2.9%	$70.71 +13.2%	+106.1%	$12.36B	$12.91B	37.64	23,500	Positive News
FMS Fresenius Medical Care AG & Co. KGaA	2.6586 of 5 stars	$22.45 -0.9%	$23.57 +5.0%	-10.5%	$12.06B	$19.43B	11.63	1,488

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 9/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. DGX, GH, BTSG, FMS, and TEM

How does Hims & Hers Health compare to Quest Diagnostics?

Summary

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to Tempus AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. DGX, GH, BTSG, FMS, and TEM

How does Hims & Hers Health compare to Quest Diagnostics?

Does the media prefer DGX or HIMS?

Which has stronger valuation & earnings, DGX or HIMS?

Do analysts recommend DGX or HIMS?

Do insiders & institutionals have more ownership in DGX or HIMS?

Which has more risk and volatility, DGX or HIMS?

Is DGX or HIMS more profitable?

Summary

How does Hims & Hers Health compare to Guardant Health?

Which has better valuation & earnings, HIMS or GH?

Do analysts recommend HIMS or GH?

Do insiders & institutionals hold more shares of HIMS or GH?

Is HIMS or GH more profitable?

Which has more volatility & risk, HIMS or GH?

Does the media prefer HIMS or GH?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Do analysts recommend HIMS or BTSG?

Is HIMS or BTSG more profitable?

Which has stronger earnings & valuation, HIMS or BTSG?

Do institutionals and insiders believe in HIMS or BTSG?

Which has more volatility and risk, HIMS or BTSG?

Does the media prefer HIMS or BTSG?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has higher earnings and valuation, FMS or HIMS?

Do insiders & institutionals believe in FMS or HIMS?

Does the media prefer FMS or HIMS?

Do analysts recommend FMS or HIMS?

Which has more risk and volatility, FMS or HIMS?

Is FMS or HIMS more profitable?

Summary

How does Hims & Hers Health compare to Tempus AI?

Which has more volatility and risk, TEM or HIMS?

Does the media prefer TEM or HIMS?

Do analysts prefer TEM or HIMS?

Which has stronger valuation and earnings, TEM or HIMS?

Is TEM or HIMS more profitable?

Do insiders and institutionals have more ownership in TEM or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools